FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to compositions and methods for prevention or treatment of renal fibrosis in an individual. Particularly, the method for prevention or treatment of renal fibrosis in an individual involves administering a composition containing a pharmaceutically effective amount of a vasoactive intestinal peptide (VIP) or one or more functional VIP fragments specified in VIP(10-28), VIP(4-12), VIP(4-16), VIP(4-20), VIP(4-24), VIP(6-10), VIP(6-12), VIP(6-16), VIP(6-20), VIP(6-24) or conventional substitutes thereof into the individual exposed to a risk of developing renal fibrosis or suffering from renal fibrosis.
EFFECT: using the group of invention enables preventing or delaying developing renal fibrosis in the individual more effectively.
15 cl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR TREATMENT OF AORTA FIBROSIS | 2010 |
|
RU2536223C2 |
| COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASE | 2005 |
|
RU2387454C2 |
| PEGILATED BIOLOGICALLY ACTIVE PEPTIDES AND THEIR APPLICATION | 2017 |
|
RU2748576C2 |
| FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE | 2020 |
|
RU2804335C2 |
| METHODS OF TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | 2012 |
|
RU2743409C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| ANTIBODIES TO CD40 AND METHODS OF USE THEREOF | 2016 |
|
RU2715597C2 |
| VIP FRAGMENTS AND METHODS FOR USING THEM | 2006 |
|
RU2466738C2 |
| APPLICATION OF AN ANTIBODY TO PD-1 IN COMBINATION WITH FAMITINIB FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING TUMOURS | 2019 |
|
RU2783846C1 |
| METHODS OF TREATING TISSUE CALCIFICATION | 2015 |
|
RU2770698C2 |
